Qiagen to pay Oxford Immunotec $27.5 million to settle patent case
Qiagen to pay Oxford Immunotec $27.5 million to settle patent case Reuters Full coverage
In: PATENT NEWS
Qiagen to pay Oxford Immunotec $27.5 million to settle patent case Reuters Full coverage
In: PATENT NEWS
Just when it appeared that FIFA, the governing body of world soccer, was emerging from its morass of legal problems, the organization is back in trouble with the law. Its latest misdeed? It has been accused of using a proprietary foam without respecting and supporting the patents of its inventor.
In: PATENT NEWS
Gov’t Says High Court Should Wait on Business Patent Challenges Bloomberg BNA Full coverage
In: PATENT NEWS
Law360, New York (December 15, 2017, 5:48 PM EST) — A Delaware federal judge on Thursday refused a drug and medical device maker’s request to dismiss or transfer an infringement suit brought against it over three intravenous painkiller patents, greenlighting discovery to determine if the venue is …
In: PATENT NEWS
… Friday that an inventor’s $7 million in patent royalties do not count as capital gains under federal tax law, upholding a U.S. Tax Court decision and rejecting … At issue was James Cooper’s claim that he had transferred all rights to the patents to the company called Technology Licensing... Continue reading
In: PATENT NEWS
With decades of global patent law experience, Dion M. Bregman focuses on patent litigation, prosecution, and counseling, and represents public and private companies in the software, hardware, media, Internet, telecommunications, medical device, aerospace, business methods, graphical user …
In: PATENT NEWS
The 17th Annual Berkeley-Stanford Advanced Patent Law Institute featured Berkeley’s nationally recognized faculty as well as leading judges, professors, litigators, patent attorneys and senior IP counsel from major corporations. Ken presented a keynote on December 8th on “What Robots and AI Can …
In: PATENT NEWS
… prosecute or enforce licensed patents; failure to comply with our obligations under our license agreements; effects of patent or other intellectual property lawsuits; failure to protect our intellectual property; changing patent laws and regulations; non-compliance with any legal or regulatory requirements; …
In: PATENT NEWS
Oxford Immunotec and QIAGEN NV Settle Patent Infringement Lawsuit Nasdaq Full coverage
In: PATENT NEWS
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Ltd. (Nasdaq:OXFD) and QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt Stock Exchange:QIA) announced today that they have reached a settlement in the lawsuit in the U.S. District Court for the …
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION